Skip to main content

Brennan Daniel J.'s Form 4 filing

Boston Scientific CorpBSX · filed Feb 13, 2025

Accession no.
0001225208-25-001679
Filed
Feb 13, 2025
Trade date
Feb 11-12, 2025
Filing delay
2 days
Rule 10b5-1 plan
Checked

This filing lists 4 non-derivative transactions and 1 derivative transaction. Open-market sales total $1.59M. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Brennan Daniel J.CIK 0001595612Officer (EVP and CFO)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Feb 11, 2025Common StockAGrant or awardAcquired+33,944$0.00$0257,865Direct
Feb 11, 2025Common StockFTax withholdingDisposed−16,414$105.98−$1,739,555.72241,451Direct
Feb 12, 2025Common StockMOption exerciseAcquired+15,087$16.31+$246,068.97256,538Direct
Feb 12, 2025Common StockSSaleDisposed−15,087$105.07F3−$1,585,191.09241,451Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Feb 12, 2025Common StockMOption exerciseDisposed−15,087$0.00$00Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F3

Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $104.778 to $105.28, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)